Literature DB >> 1875169

Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype.

J Sprent1, M Schaefer, M Hurd, C D Surh, Y Ron.   

Abstract

To seek information on the potential lifespan of normal B and T lymphocytes, lymph node (LN) cells from unprimed mice were transferred to H-2-identical severe combined immunodeficiency (SCID) hosts. At a population level, the donor B and T cells survived for at least 10 mo post-transfer with no reduction in their numbers. In terms of antibody production, LN-injected SCID mice remained responsive to several different antigens and contained unprimed precursors of memory cells for greater than or equal to 6 mo post-transfer. Most of the B and T cells recovered from LN-injected SCID mice expressed the typical virgin phenotype of mature lymphocytes from young mice. These findings suggest that many of the transferred lymphocytes might have remained in interphase as virgin cells from the time of injection. This did not apply to all of the transferred cells, however, because 20-40% of CD4+ cells from long-term SCID hosts displayed a memory phenotype, 7% incorporated 2-bromodeoxyuridine over 5 d, and total numbers of B and T cells increased gradually (twofold) over a 10-mo period. Collectively, the data favor the view that the pool of mature B and T cells in adult mice is largely self sufficient: some of the cells proliferate, presumably in response to environmental antigens, but many mature cells can remain quiescent for prolonged periods. Input of new cells from the primary lymphoid organs continues, but at a much reduced rate relative to young life.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1875169      PMCID: PMC2118939          DOI: 10.1084/jem.174.3.717

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Interconversion of CD45R subsets of CD4 T cells in vivo.

Authors:  E B Bell; S M Sparshott
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

2.  The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.

Authors:  C A Janeway; J Ron; M E Katz
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

3.  Development and physiology of Ly-1 B and its human homolog, Leu-1 B.

Authors:  R R Hardy; K Hayakawa
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

4.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

5.  Ly-24 (Pgp-1) expression by thymocytes and peripheral T cells.

Authors:  F Lynch; R Ceredig
Journal:  Immunol Today       Date:  1988-01

6.  T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.

Authors:  Y Ron; J Sprent
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

7.  Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo.

Authors:  B Rocha; N Dautigny; P Pereira
Journal:  Eur J Immunol       Date:  1989-05       Impact factor: 5.532

8.  Lymphocyte populations in mouse bone marrow: quantitative kinetic studies in young, pubertal and adult C3H mice.

Authors:  S C Miller; D G Osmond
Journal:  Cell Tissue Kinet       Date:  1975-03

9.  Capacity of unprimed CD4+ and CD8+ T cells expressing V beta 11 receptors to respond to I-E alloantigens in vivo.

Authors:  E K Gao; O Kanagawa; J Sprent
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.

Authors:  J Sprent; M Schaefer
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  40 in total

Review 1.  Differences in the regulation of CD4 and CD8 T-cell clones during immune responses.

Authors:  P C Beverley; M K Maini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

Review 2.  T cell-mediated antigen presentation: a potential mechanism of infectious tolerance.

Authors:  M D Mannie
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

Authors:  R P Bucy; R D Hockett; C A Derdeyn; M S Saag; K Squires; M Sillers; R T Mitsuyasu; J M Kilby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 4.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

Review 5.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

6.  Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes.

Authors:  E T Zambidis; A Kurup; D W Scott
Journal:  Mol Med       Date:  1997-03       Impact factor: 6.354

7.  Analysis of naïve lung CD4 T cells provides evidence of functional lung to lymph node migration.

Authors:  Stephane M Caucheteux; Parizad Torabi-Parizi; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

8.  p53-mediated hematopoietic stem and progenitor cell competition.

Authors:  Tanya Bondar; Ruslan Medzhitov
Journal:  Cell Stem Cell       Date:  2010-04-02       Impact factor: 24.633

9.  A murine model for B-lymphocyte somatic cell gene therapy.

Authors:  N Sutkowski; M L Kuo; A Varela-Echavarria; J P Dougherty; Y Ron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 10.  Non-human primate models of T-cell reconstitution.

Authors:  Janko Nikolich-Zugich
Journal:  Semin Immunol       Date:  2007-11-19       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.